Leqembi is an amyloid beta-directed antibody indicated for treating Alzheimer’s disease. Leqembi is intended to treat patients with mild cognitive impairment or experiencing the mild dementia stage of the disease.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
Biologics (monoclonal antibodies)
WHAT IT TREATS:
Every two weeks
Length of infusion:
About one hour
FOR MORE INFORMATION: